Products for Research Use Only
RegisterLogin

SNX-2112

CAT: 0804-HY-10214-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10214-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SNX-2112 (PF 04928473) is an orally active Hsp90 inhibitor, with a Kd of 16 nM for Hsp90 and IC50s of 30 nM, 30 nM for Hsp90 α and Hsp90 β, also induces Her-2 degradation, and inhibits Grp94 and Trap-1, with IC50s of 10 nM, 4.275 μM and 0.862 μM, respectively[1]. SNX-2112 (PF 04928473) binds Hsp90 isoforms Hsp90α, Hsp90β and Hsp90b1/Grp94 with Kds of 4 nM, 6 nM and 484 nM, respectively[2].
CAS Number
908112-43-6
Product Name Alternative
PF-04928473
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
Autophagy; HSP
Type
Reference compound
Related Pathways
Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/SNX-2112.html
Purity
99.49
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
FC(F)(C1=NN(C2=CC(N[C@@H]3CC[C@H](CC3)O)=C(C=C2)C(N)=O)C(CC(C)(C4)C)=C1C4=O)F
Molecular Formula
C23H27F3N4O3
Molecular Weight
464.48
Precautions
H315, H319, H320
References & Citations
[1]Huang KH, et al. Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents. J Med Chem. 2009 Jul 23;52 (14) :4288-305|[2]Chandarlapaty S, et al. SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Clin Cancer Res. 2008 Jan 1;14 (1) :240-8.|[3]Okawa Y, et al. SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK. Blood. 2009 Jan 22;113 (4) :846-55.|[4]Mishra SJ, et al. Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold. ACS Chem Biol. 2017 Jan 20;12 (1) :244-253.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HSP70; HSP90

Related Products

CatalogName
HY-155310-01AF-2112
HY-P1074SNX-482
HY-119046-01SNX-0723
HY-10213-01SNX-5422
HY-10213ASNX-5422 (mesylate)
HY-176884CDD-2110
HY-139307-01MG-2119
HY-163668-01MK-2118
HY-100898-01OGT 2115
HY-11041LSP1-2111

Alternative Products

CatalogName
A4068-5SNX-2112
M16526-01SNX 2112

Popular Products